home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/0ba55a17-08a1-4757-9fc7-5761ff8f78b1_Harnessing innovative technologies for clinical trials involving emerging and reemerging
whitepaper
SHARESHARESHARE
HARNESSING INNOVATIVE TECHNOLOGIES
Introduction: The rise of the super-bug in today’s world, the biodiversity of vital ecosystems is threatened by factors, such as overpopulation, deforestation, mass migrations, war, famine, depletion of natural resources and animal-human interactions.1 These elements are increasing the sharing of microbial agents and antimicrobial resistance, which can facilitate the emergence of new or previously recognized disease agents. The damaging effects of antimicrobial resistance are increasingly being seen around the world. This issue recently hit the headlines with an industry declaration on combating antimicrobial resistance at the World Economic Forum in Davos, Switzerland. DOWNLOAD